Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > who
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(640)
•••
Comment by okgonowon Oct 04, 2023 3:15pm
52 Views
Post# 35669609

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:who

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:whoAgain allysome FYI

Cannabidiol Suppliers

A Cannabidiol supplier is an individual or a company that provides Cannabidiol active pharmaceutical ingredient (API) or Cannabidiol finished formulations upon request. The Cannabidiol suppliers may include Cannabidiol API manufacturers, exporters, distributors and traders.

CLICK HERE to find a list of Cannabidiol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Cannabidiol Manufacturers | Traders | Suppliers

We have 34 companies offering Cannabidiol

Get in contact with the supplier of your choice:

  1. Transo-Pharm USA LLC
  2. Malladi Drugs & Pharmaceuticals Limited
  3. Biophore India Pharmaceuticals Pvt Ltd
  4. Noramco
  5. Purisys LLC
  6. Laboratorium Ofichem B.V
  7. Veranova
  8. Royal DSM
  9. MediPharm Labs
  10. Endofar
  11. Curia
  12. Axplora
  13. Agno Pharma
  14. Alkem Laboratories
  15. Ananda Scientific
  16. Arevipharma
  17. Averix Bio
  18. Benuvia Therapeutics
  19. Botanix Pharma
  20. Embio Limited
  21. Evergreen State Holdings
  22. Farmakem
  23. GW Pharmaceutical
  24. Indena
  25. NATIONAL CENTER FOR NATURAL PRODUCTS RESEARCH
  26. Prati-Donaduzzi
  27. SCI PHARMTECH
  28. Sequoya
  29. STI PHARMA
  30. THC Pharm
  31. Vantage Hemp
  32. Xian Tian Guangyuan Biotech
  33. Yunnan Hansu Biotechnology
  34. ZCL Chemicals Limited

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities